Clinical Trial

CALLY Index, Frailty and SOFA-2 for Mortality Prediction in Geriatric ICU Patients

Study acronym: CALLY-FS
Completed
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the prognostic value of the C-reactive protein-albumin-lymphocyte (CALLY) index, Clinical Frailty Scale (CFS), and SOFA-2 score in predicting mortality among geriatric intensive care unit (ICU) patients. The primary outcome is ICU mortality. Secondary outcomes include 28-day mortality, ICU length of stay, duration of mechanical ventilation, need for renal replacement therapy, and vasopressor requirement. The study also investigates whether the combined use of these parameters improves predictive performance compared to conventional scoring systems such as APACHE II.
Protocol Amendment History 2 changes
critical Trial completed 2026-07-10
notable Enrollment increased: 100 -> 138 participants 2026-07-10
Trial Details
NCT Number NCT07579728
Lead Sponsor Istanbul University - Cerrahpasa
Conditions Critical Illness, Frailty, Intensive Care Unit (ICU)
Enrollment 138 participants
Start Date 2026-04-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-07-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-09